Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
17.87
+0.07 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Avanos Medical Market Cap
Avanos Medical has a market cap or net worth of $771.29 million as of November 21, 2024. Its market cap has decreased by -21.63% in one year.
Market Cap
771.29M
Enterprise Value
884.49M
1-Year Change
-21.63%
Ranking
Category
Stock Price
$17.87
Market Cap Chart
Since October 21, 2014, Avanos Medical's market cap has decreased from $1.91B to $771.29M, a decrease of -59.58%. That is a compound annual growth rate of -8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 821.30M | -21.13% |
| Dec 29, 2023 | 1.04B | -17.24% |
| Dec 30, 2022 | 1.26B | -24.69% |
| Dec 31, 2021 | 1.67B | -23.88% |
| Dec 31, 2020 | 2.19B | 35.87% |
| Dec 31, 2019 | 1.62B | -23.97% |
| Dec 31, 2018 | 2.12B | -1.78% |
| Dec 29, 2017 | 2.16B | 25.31% |
| Dec 30, 2016 | 1.73B | 10.83% |
| Dec 31, 2015 | 1.56B | -26.40% |
| Dec 31, 2014 | 2.12B | 10.90% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 818.50M |
| Tyra Biosciences | 817.93M |
| Autolus Therapeutics | 795.62M |
| Cullinan Therapeutics | 783.16M |
| AbCellera Biologics | 782.72M |
| Castle Biosciences | 781.40M |
| Rapport Therapeutics | 780.18M |
| Avid Bioservices | 777.70M |